{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:07:44Z","timestamp":1793138864085,"version":"4.5.0"},"reference-count":37,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The treatment and medical management of aplastic anemia fundamentally differ between patients with inherited versus acquired marrow failure; however, the diagnosis of an inherited bone marrow failure syndrome is frequently obscure. Recent exciting advances in our understanding of the molecular pathophysiology of the inherited bone marrow failure syndromes have resulted in a profusion of new tests to aid in diagnosis. This in turn has raised questions regarding the appropriate choice of testing for the patient presenting with aplastic anemia. Important clues to the diagnosis of an inherited marrow failure syndrome may be gleaned from careful attention to the clinical history, physical exam, and laboratory workup.<\/jats:p>","DOI":"10.1182\/asheducation-2009.1.329","type":"journal-article","created":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T20:35:31Z","timestamp":1260563731000},"page":"329-337","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":26,"title":["Clinical approach to marrow failure"],"prefix":"10.1182","volume":"2009","author":[{"given":"Akiko","family":"Shimamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111703412791700_R1","doi-asserted-by":"crossref","unstructured":"Myers KC, Davies SM. Hematopoietic stem cell transplantation for bone marrow failure syndromes in children. Biol Blood Marrow Transplant. 2009;15:279\u2013292.","DOI":"10.1016\/j.bbmt.2008.11.037"},{"key":"2019111703412791700_R2","doi-asserted-by":"crossref","unstructured":"Rosenberg PS, Socie G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood. 2005;105:67\u201373.","DOI":"10.1182\/blood-2004-04-1652"},{"key":"2019111703412791700_R3","doi-asserted-by":"crossref","unstructured":"Green AM, Kupfer GM. Fanconi anemia. Hematol Oncol Clin North Am. 2009;23:193\u2013214.","DOI":"10.1016\/j.hoc.2009.01.008"},{"key":"2019111703412791700_R4","doi-asserted-by":"crossref","unstructured":"Savage SA, Alter BP. Dyskeratosis congenita. Hematol Oncol Clin North Am. 2009;23:215\u2013231.","DOI":"10.1016\/j.hoc.2009.01.003"},{"key":"2019111703412791700_R5","doi-asserted-by":"crossref","unstructured":"Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110:768\u2013779.","DOI":"10.1046\/j.1365-2141.2000.02109.x"},{"key":"2019111703412791700_R6","doi-asserted-by":"crossref","unstructured":"Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet. 2008;82:501\u2013509.","DOI":"10.1016\/j.ajhg.2007.10.004"},{"key":"2019111703412791700_R7","doi-asserted-by":"crossref","unstructured":"Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood. 2009;113:6549\u20136551.","DOI":"10.1182\/blood-2008-12-192880"},{"key":"2019111703412791700_R8","doi-asserted-by":"crossref","unstructured":"Nakanishi K, Taniguchi T, Ranganathan V, et al. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol. 2002;4:913\u2013920.","DOI":"10.1038\/ncb879"},{"key":"2019111703412791700_R9","doi-asserted-by":"crossref","unstructured":"Lo Ten Foe JR, Kwee ML, Rooimans MA, et al. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet. 1997;5:137\u2013148.","DOI":"10.1159\/000484749"},{"key":"2019111703412791700_R10","doi-asserted-by":"crossref","unstructured":"Gregory JJ Jr, Wagner JE, Verlander PC, et al. Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proc Natl Acad Sci U S A. 2001;98:2532\u20132537.","DOI":"10.1073\/pnas.051609898"},{"key":"2019111703412791700_R11","doi-asserted-by":"crossref","unstructured":"Wagner JE, Tolar J, Levran O, et al. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood. 2004;103:3226\u20133229.","DOI":"10.1182\/blood-2003-09-3138"},{"key":"2019111703412791700_R12","doi-asserted-by":"crossref","unstructured":"Alter BP, Rosenberg PS, Brody LC. Clinical and molecular features associated with biallelic mutations in FANCD1\/BRCA2. J Med Genet. 2007;44:1\u20139.","DOI":"10.1136\/jmg.2006.043257"},{"key":"2019111703412791700_R13","doi-asserted-by":"crossref","unstructured":"Reid S, Schindler D, Hanenberg H, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet. 2007;39:162\u2013164.","DOI":"10.1038\/ng1947"},{"key":"2019111703412791700_R14","doi-asserted-by":"crossref","unstructured":"Alter BP, Baerlocher GM, Savage SA, et al. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood. 2007;110:1439\u20131447.","DOI":"10.1182\/blood-2007-02-075598"},{"key":"2019111703412791700_R15","doi-asserted-by":"crossref","unstructured":"Du HY, Pumbo E, Ivanovich J, et al. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood. 2009;113:309\u2013316.","DOI":"10.1182\/blood-2008-07-166421"},{"key":"2019111703412791700_R16","doi-asserted-by":"crossref","unstructured":"Ip WF, Dupuis A, Ellis L, et al. Serum pancreatic enzymes define the pancreatic phenotype in patients with Shwachman-Diamond syndrome. J Pediatr. 2002;141:259\u2013265.","DOI":"10.1067\/mpd.2002.125849"},{"key":"2019111703412791700_R17","doi-asserted-by":"crossref","unstructured":"Rothbaum R, Perrault J, Vlachos A, et al. Shwachman-Diamond syndrome: report from an international conference. J Pediatr. 2002;141:266\u2013270.","DOI":"10.1067\/mpd.2002.125850"},{"key":"2019111703412791700_R18","doi-asserted-by":"crossref","unstructured":"Vlachos A, Ball S, Dahl N, et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol. 2008;142:859\u2013876.","DOI":"10.1111\/j.1365-2141.2008.07269.x"},{"key":"2019111703412791700_R19","doi-asserted-by":"crossref","unstructured":"Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet. 2007;8:735\u2013748.","DOI":"10.1038\/nrg2159"},{"key":"2019111703412791700_R20","doi-asserted-by":"crossref","unstructured":"de Winter JP, Joenje H. The genetic and molecular basis of Fanconi anemia. Mutat Res. 2008;668:11\u201319.","DOI":"10.1016\/j.mrfmmm.2008.11.004"},{"key":"2019111703412791700_R21","doi-asserted-by":"crossref","unstructured":"Bagby GC, Alter BP. Fanconi anemia. Semin Hematol. 2006;43:147\u2013156.","DOI":"10.1053\/j.seminhematol.2006.04.005"},{"key":"2019111703412791700_R22","doi-asserted-by":"crossref","unstructured":"Vulliamy T, Dokal I. Dyskeratosis congenita. Semin Hematol. 2006;43:157\u2013166.","DOI":"10.1053\/j.seminhematol.2006.04.001"},{"key":"2019111703412791700_R23","doi-asserted-by":"crossref","unstructured":"Meier UT. The many facets of H\/ACA ribonucleoproteins. Chromosoma. 2005;114:1\u201314.","DOI":"10.1007\/s00412-005-0333-9"},{"key":"2019111703412791700_R24","doi-asserted-by":"crossref","unstructured":"Burroughs L, Woolfrey A, Shimamura A. Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin North Am. 2009;23:233\u2013248.","DOI":"10.1016\/j.hoc.2009.01.007"},{"key":"2019111703412791700_R25","doi-asserted-by":"crossref","unstructured":"Boocock GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet. 2003;33:97\u2013101.","DOI":"10.1038\/ng1062"},{"key":"2019111703412791700_R26","doi-asserted-by":"crossref","unstructured":"Menne TF, Goyenechea B, Sanchez-Puig N, et al. The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat Genet. 2007;39:486\u2013495.","DOI":"10.1038\/ng1994"},{"key":"2019111703412791700_R27","doi-asserted-by":"crossref","unstructured":"Austin KM, Gupta ML, Coats SA, et al. Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J Clin Invest. 2008;118:1511\u20131518.","DOI":"10.1172\/JCI33764"},{"key":"2019111703412791700_R28","doi-asserted-by":"crossref","unstructured":"Orelio C, Kuijpers TW. Shwachman-Diamond syndrome neutrophils have altered chemoattractant-induced F-actin polymerization and polarization characteristics. Haematologica. 2009;94:409\u2013413.","DOI":"10.3324\/haematol.13733"},{"key":"2019111703412791700_R29","doi-asserted-by":"crossref","unstructured":"Geddis AE. Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Hematol Oncol Clin North Am. 2009;23:321\u2013331.","DOI":"10.1016\/j.hoc.2009.01.012"},{"key":"2019111703412791700_R30","doi-asserted-by":"crossref","unstructured":"King S, Germeshausen M, Strauss G, Welte K, Ballmaier M. Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients. Br J Haematol. 2005;131:636\u2013644.","DOI":"10.1111\/j.1365-2141.2005.05819.x"},{"key":"2019111703412791700_R31","doi-asserted-by":"crossref","unstructured":"Giri N, Kang E, Tisdale JF, et al. Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia. Br J Haematol. 2000;108:167\u2013175.","DOI":"10.1046\/j.1365-2141.2000.01796.x"},{"key":"2019111703412791700_R32","doi-asserted-by":"crossref","unstructured":"Lipton JM, Ellis SR. Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis. Hematol Oncol Clin North Am. 2009;23:261\u2013282.","DOI":"10.1016\/j.hoc.2009.01.004"},{"key":"2019111703412791700_R33","doi-asserted-by":"crossref","unstructured":"Gazda HT, Sheen MR, Vlachos A, et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet. 2008;83:769\u2013780.","DOI":"10.1016\/j.ajhg.2008.11.004"},{"key":"2019111703412791700_R34","doi-asserted-by":"crossref","unstructured":"Ebert BL, Pretz J, Bosco J, et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature. 2008;451:335\u2013339.","DOI":"10.1038\/nature06494"},{"key":"2019111703412791700_R35","doi-asserted-by":"crossref","unstructured":"Gilkes DM, Chen L, Chen J. MDMX regulation of p53 response to ribosomal stress. EMBO J. 2006;25:5614\u20135625.","DOI":"10.1038\/sj.emboj.7601424"},{"key":"2019111703412791700_R36","doi-asserted-by":"crossref","unstructured":"McGowan KA, Li JZ, Park CY, et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet. 2008;40:963\u2013970.","DOI":"10.1038\/ng.188"},{"key":"2019111703412791700_R37","doi-asserted-by":"crossref","unstructured":"Fumagalli S, Di Cara A, Neb-Gulati A, et al. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol. 2009;11:501\u2013508.","DOI":"10.1038\/ncb1858"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2009\/1\/329\/645447\/328_337ash.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2009\/1\/329\/645447\/328_337ash.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T08:41:52Z","timestamp":1573980112000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2009\/1\/329\/19818\/Clinical-approach-to-marrow-failure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2009.1.329","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,1]]}}}